Diagnostic value of only 18f-fluorodeocyglucose positron emission tomography/computed tomography-positive lymph nodes in head and neck squamous cell carcinoma

Otolaryngology - Head and Neck Surgery (United States)

Volumn 147, Issue 4, 2012, Pages 692-698

  Lee, Sang Hyuk ^a   Huh, Se Hyung ^a   Jin, Sung Min ^a   Rho, Young Soo ^b   Yoon, Dae Young ^b   Park, Chan Hee ^b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Hallym University Medical Center   (South Korea)

Author keywords

head and neck; lymph node; metastases; PET CT; squamous cell carcinoma

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADODIAMIDE; IOHEXOL; NONIONIC CONTRAST MEDIUM; UNCLASSIFIED DRUG; UTRAVIST 300;

ADULT; AGED; CERVICAL LYMPH NODE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FALSE POSITIVE RESULT; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NECK DISSECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTIVE VALUE; REVIEW; SENSITIVITY AND SPECIFICITY; ULTRASOUND; ULTRASOUND SCANNER;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DIAGNOSTIC IMAGING; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LYMPH NODE EXCISION; LYMPH NODES; MALE; MIDDLE AGED; NECK DISSECTION; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY;

EID: 84870420283     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599812443040     Document Type: Review

References (24)

1. Shah J. Cervical lymph node metastases: diagnostic, therapeutic, and prognostic implications. Oncology. 1990 ; 4: 61-69
2. Snow GB, Patel P, Leemans CR, Tiwari R. Management of cervical lymph nodes in patients with head and neck cancer. Eur Arch Otorhinolaryngol. 1992 ; 249: 187-194
3. Barzan L, Talamini R. Analysis of prognostic factors for recurrence after neck dissection. Arch Otolaryngol Head Neck Surg. 1996 ; 122: 1299-1302 (Pubitemid 26408909)
4. Roh JL, Yeo NK, Kim JS, et al. Utility of 2-[18F] fluoro-2-deoxy-D- glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma. Oral Oncol. 2007 ; 43: 887-893 (Pubitemid 47369251)
5. Joeong HS, Baek CH, Son YI, et al. Use of integrated 18F-FDG PET/CT to improve the accuracy of initial cervical nodal evaluation in patients with head and neck squamous cell carcinoma. Head Neck. 2007 ; 29: 203-210
6. Schoder H, Yeung HW, Gonen M, Kraus D, Larson SM. Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. Radiology. 2004 ; 231: 65-72 (Pubitemid 38375411)
7. Yoon DY, Hwang HS, Chang SK, et al. CT, MR, US, 18F-FDG PET/CT, and their combined use for the assessment of cervical lymph node metastases in squamous cell carcinoma of the head and neck. Eur Radiol. 2009 ; 19: 634-642
8. Ng SH, Yen TC, Liao CT, et al. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. J Nucl Med. 2005 ; 46: 1136-1143
9. Stern WBR, Silver CE, Zeifer BA, et al. Computed tomography of the clinically negative neck. Head Neck. 1990 ; 12: 109-113 (Pubitemid 20088317)
10. Friedman M, Mafee M, Pacella BL, et al. Rationale for elective neck dissection in 1990. Laryngoscope. 1990 ; 100: 54-59 (Pubitemid 20020498)
11. Castelijns JA, van den Brekel MWM. Detection of lymph node metastases in the neck: radiologic criteria. Am J Neuroradiol. 2002 ; 22: 3-4
12. Feinmesser R, Freeman JL, Noyek AM, et al. Metastatic neck disease: a clinical/radiologic/pathological correlative study. Arch Otolaryngol Head Neck Surg. 1987 ; 113: 1307-1310 (Pubitemid 18034614)
13. Laubenbacher C, Saumweber D, Wagner-Manslau C, et al. Comparison of fluorine-18-fluorode-oxyglucose PET, MR imaging and endoscopy for staging head and neck squamous-cell carcinomas. J Nucl Med. 1995 ; 36: 1747-1757
14. Braams JW, Pruim J, Freling NJ, et al. Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MR imaging. J Nucl Med. 1995 ; 36: 211-216
15. Adams S, Baum RP, Stuckensen T, Bitter K, Hor G. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MR imaging, US) in lymph node staging of head and neck cancer. Eur J Nucl Med. 1998 ; 25: 1255-1260 (Pubitemid 28446051)
16. Syed R, Bomanji JB, Nagabhushan N, et al. Impact of combined 18F-FDG PET/CT in head and neck tumours. Br J Cancer. 2005 ; 92: 1046-1050 (Pubitemid 40546667)
17. Branstetter BF, Blodgett TM, Zimmer LA, et al. Head and neck malignancy: is PET/CT more accurate than PET or CT alone?. Radiology. 2005 ; 235: 580-586 (Pubitemid 40571100)
18. Endo K, Oriuchi N, Higuchi T, et al. PET and PET/CT using 18F-FDG in the diagnosis and management of cancer patients. Int J Clin Oncol. 2006 ; 11: 286-296 (Pubitemid 44306212)
19. Braams JW, Pruim J, Freling NJ, et al. Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI. J Nucl Med. 1995 ; 36: 211-216
20. Kau RJ, Alexiou C, Laubenbacher C, Werner M, Schwaiger M, Arnold W. Lymph node detection of head and neck squamous cell carcinomas by positron emission tomography with fluorodeoxyglucose F18 in a routine clinical setting. Arch Otolaryngol Head Neck Surg. 1999 ; 125: 1322-1328
21. Laubenbacher C, Saumweber D, Wagner-Manslau C, et al. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. J Nucl Med. 1995 ; 36: 1747-1757
22. Shöder H, Carison DL, Kraus DH, et al. 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI. J Nucl Med. 2006 ; 47: 755-762 (Pubitemid 46768437)
23. Haberkorn U, Strauss LG, Reisser C, et al. Glucose uptake, perfusion and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry. J Nucl Med. 1991 ; 32: 1548-1555
24. Fleming AJ, Johansen ME. The clinician's expectations from the use of positron emission tomography/computed tomography scanning in untreated and treated head and neck cancer patients. Curr Opin Otolaryngol Head Neck Surg. 2008 ; 16: 127-134 (Pubitemid 351354967)